Mars Bioimaging Company
Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking MARS imaging system for its applications in medical diagnosis.
The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.
Headquarters:
-43.5367262
Industry:
Sensing/Imaging/Diagnostics
Super Industry:
Quantum Medicine
Funding Stage:
Early Stage Venture
Funding Total Value:
15500000
Last Funding Total Usd:
15000000
Last Funding Total Currency:
USD
Last Funding Total Value:
15000000
Founders:
Mark Figgit,Phil Butler